FSSAI flags HUL’s ‘happy birth weight’ claim, Nestlé’s nutrition supplement over labelling concerns

FSSAI’s notices focus on whether packaging gives consumers accurate, regulation-compliant information. The regulator said some health and nutrition claims made by Nestlé India and Hindustan Unilever were misleading or did not meet applicable rules. It also identified a missing label detail and a missing prior approval.

Nestlé’s Resource Renal Vanilla Flavour Powder carried claims including “Nutrition for Strong Bones,” “Clinically Proven to Help Improve Bone Strength in 6 Months,” and “Improves Bone Health.” FSSAI said the product was intended for people managing a medical condition, yet lacked prior approval and did not state whether it was vegetarian or non-vegetarian. HUL’s Horlicks Mother’s Plus Kesar carried a “happy birth weight” claim. Horlicks Women’s Plus products included bone-health, muscle, and “no added sugar” claims.

FSSAI sought responses from both companies. HUL said its products comply with applicable requirements and promised scientific and regulatory evidence. Nestlé had not immediately commented when the report was published.

The Food Safety and Standards Authority of India, or FSSAI, is India’s federal regulator for food safety and standards. Under the Food Safety and Standards Act, 2006, it sets food-related standards and oversees compliance across food businesses. This broader legal authority is established knowledge; the article specifically identifies FSSAI as India’s food regulator and describes its enforcement actions.

Its role includes examining whether products, labels, and promotional claims follow applicable food rules. In the reported case, FSSAI questioned claims on Nestlé and Hindustan Unilever products. It also alleged that Nestlé’s Resource Renal Vanilla Flavour Powder lacked prior approval and failed to display its vegetarian or non-vegetarian status.

FSSAI can seek explanations and initiate enforcement action when it identifies possible violations. The article says it sought responses from both companies and has recently acted against manufacturers, hotels, restaurants, and online platforms. It does not specify the final penalties in these notices.

The notices named two companies: Nestlé India and Hindustan Unilever Ltd. Three product lines were identified in the report. Nestlé’s Resource Renal Vanilla Flavour Powder was one. HUL’s products included Horlicks Mother’s Plus Kesar 400 g BIB and Horlicks Women’s Plus products.

FSSAI questioned several kinds of claims. For Nestlé, it flagged “Nutrition for Strong Bones,” “Clinically Proven to Help Improve Bone Strength in 6 Months,” and “Improves Bone Health.” For HUL, it raised concerns about “happy birth weight,” “improves bone health,” “healthy muscles,” and “no added sugar.” The regulator described the claims as misleading or contrary to its rules.

The article does not give a total number of individual products within the Horlicks Women’s Plus range. FSSAI sought responses from both companies. HUL said it would provide scientific and regulatory evidence, while Nestlé had not immediately responded.

Health claims can influence purchasing decisions, especially when they suggest measurable medical or nutritional benefits. Words such as “clinically proven” sound stronger than ordinary advertising and may lead consumers to expect reliable results. Claims about birth weight, bones, or muscles can also matter to people making decisions about children, pregnancy, or health management.

In the article, FSSAI questioned Nestlé’s statement that its powder was “Clinically Proven to Help Improve Bone Strength in 6 Months.” It also flagged “Improves Bone Health,” “healthy muscles,” and HUL’s “happy birth weight” wording. HUL said it would share scientific and regulatory evidence, showing that evidence is central to resolving the dispute.

The regulator said the claims were misleading or non-compliant with applicable rules. The companies now have an opportunity to respond. The article does not state whether the evidence will ultimately validate or reject the claims, so the notices are allegations rather than final findings.

FSSAI’s notices begin a regulatory process. The regulator has alleged that certain claims or labels violate food-safety rules and has asked both companies to respond. The article does not state a final penalty, product recall, suspension, or court outcome. Therefore, any further consequence depends on the companies’ explanations and FSSAI’s assessment.

For the companies, a confirmed violation could require changes to packaging, marketing, or product compliance, and could lead to additional legal or regulatory action. The article records that FSSAI previously initiated legal action against Nestlé India in September over infant nutrition marketing rules and substandard manufacturing. It does not specify the result of that action.

For consumers, misleading claims can make a product appear more effective, suitable, or complete than the regulator believes it is. That may affect purchasing and health-related choices. FSSAI’s wider scrutiny is intended to address misleading labels and inappropriate marketing, but the article gives no confirmed consumer remedy in this case.

A product intended for people managing a medical condition can affect consumers who have specific health needs. They may rely heavily on the product’s stated purpose, ingredients, and directions. Special scrutiny helps regulators check whether the product has the required approval and whether its presentation gives accurate information. This explanation reflects general regulatory reasoning; the article specifically reports FSSAI’s concerns about this product.

The product in question was Nestlé’s Resource Renal Vanilla Flavour Powder. FSSAI said it was intended as a dietary supplement for managing a medical condition. According to the regulator, Nestlé had not sought prior approval. The label also did not say whether the product was vegetarian or non-vegetarian.

FSSAI treated those issues as violations of food-safety rules and asked Nestlé to respond. The article does not state whether the company will change the product, obtain approval, or face a final penalty. Nestlé had not immediately responded to the request for comment when the report was published.

Food labels help consumers compare products and understand their stated purpose, contents, and claimed benefits. Clear labels support informed choices. Accurate wording matters even more when a product is presented as supporting bones, muscles, birth outcomes, or a medical condition. This is why regulators examine both label details and promotional claims.

The article gives two examples. Nestlé’s Resource Renal Vanilla Flavour Powder allegedly lacked a vegetarian or non-vegetarian declaration and carried claims about bone strength and bone health. HUL products carried claims including “happy birth weight,” “healthy muscles,” and “no added sugar.” FSSAI said these claims were misleading or contrary to applicable rules.

The public-health risk is that consumers may trust an unsupported benefit or overlook important product information. The article does not report specific harm to consumers from these products. However, it says FSSAI has intensified scrutiny after complaints about poor product standards, suggesting that accurate labelling remains a continuing regulatory priority.